Day 4 Notes from the 41st Annual J.P. Morgan Healthcare Conference
Healthcare Law Blog
JANUARY 13, 2023
Headspace Health, which is the result of the merger of Ginger and Headspace, is focused primarily on a B2B strategy of servicing employers and health plans. There are a lot of “blockbuster” drugs coming to market today and in the near future with eye-watering price tags. Their CEO, Russell Glass, had some interesting perspectives.
Let's personalize your content